U.S. markets open in 7 hours 46 minutes
  • S&P Futures

    4,165.50
    +10.00 (+0.24%)
     
  • Dow Futures

    34,050.00
    +92.00 (+0.27%)
     
  • Nasdaq Futures

    13,920.50
    +23.25 (+0.17%)
     
  • Russell 2000 Futures

    2,234.60
    +5.30 (+0.24%)
     
  • Crude Oil

    64.00
    +0.62 (+0.98%)
     
  • Gold

    1,771.30
    +0.70 (+0.04%)
     
  • Silver

    25.99
    +0.15 (+0.59%)
     
  • EUR/USD

    1.2063
    +0.0022 (+0.18%)
     
  • 10-Yr Bond

    1.6010
    0.0000 (0.00%)
     
  • Vix

    17.29
    +1.04 (+6.40%)
     
  • GBP/USD

    1.3994
    +0.0010 (+0.07%)
     
  • USD/JPY

    108.2100
    +0.0600 (+0.06%)
     
  • BTC-USD

    54,875.63
    -1,980.84 (-3.48%)
     
  • CMC Crypto 200

    1,235.10
    -63.85 (-4.92%)
     
  • FTSE 100

    7,000.08
    -19.45 (-0.28%)
     
  • Nikkei 225

    29,052.01
    -633.36 (-2.13%)
     

Burcon to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021

  • Oops!
    Something went wrong.
    Please try again later.
Newsfile Corp.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

Vancouver, British Columbia--(Newsfile Corp. - March 4, 2021) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BUROF) a global technology leader in the development of plant-based proteins, today announced that it will participate in the 33rd Annual ROTH Conference, which will be held virtually on March 15-17, 2021.

Management will host 1x1 virtual investor meetings during the conference.

For more information or to schedule a one-on-one meeting with management, please contact your ROTH representative or James@HaydenIR.com.

About ROTH Capital Partners

ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.

About Burcon NutraScience Corporation

Burcon is a global technology leader in the development of plant-based proteins. With over 300 issued patents and more than 225 additional patent applications that have been developed over a span of more than twenty years, Burcon has grown an extensive portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation was established in a joint venture by Burcon and three veteran food industry executives. Merit Foods has built a state-of-the-art protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients. For more information visit www.burcon.ca.

Forward-Looking Information Cautionary Statement

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward looking statements or forward-looking information can be identified by words such as "anticipate," "intend," "plan," "goal," "project," "estimate," "expect," "believe", "future," "likely," "may," "should," "could", "will" and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding the expected use of proceeds contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the actual results of business negotiations, marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form dated June 29, 2020 filed with the Canadian securities administrators on www.sedar.com. Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.

Industry Contact
Paul Lam
Manager, Business Development and IRO
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca

Investor Contact
James Carbonara
Hayden IR
Tel (646) 755-7412
james@haydenir.com

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/76001